What es
AELMHU?
We are a non-profit association made up of pharmaceutical companies, specialised in rare diseases, that are committed to discovering, researching, developing and commercialising innovative therapies that improve the lives of patients and their families.
AccessReport
AELMHU prepares, on a quarterly and annual basis,
reports on access to orphan drugs in Spain.
NEWS
NEWS
With the aim of highlighting the benefits of orphan therapies, not only for patients and their families, but also in economic terms for the health system, the document "Differential aspects of orphan therapies" has been presented in ... Read more
Comentarios de AELMHU
al PEMPPCyL
Awards Ceremony
AELMHU 2024 Awards
AELMHU and the Consejo General de Colegios Farmacéuticos (General Council of Pharmaceutical Associations)
Report on clinical trials
in Spain
INTERVIEWS
INTERVIEWS
Entrevista con el Dr. Jorge Francisco Gómez Cerezo, jefe del Servicio de Medicina Interna en el Hospital Universitario Infanta Sofía y Coordinador del Grupo de Enfermedades Minoritarias de la SEMI
Entrevista con Jordi Cruz, director de MPS Lisosomales, y al Dr. Álvaro Hermida, clínico especializado en este tipo de patologías
ASSOCIATED COMPANIES
RESEARCH AND COMMITMENT to rare diseases
MEMBERS
Do you want to be part of AELMHU?
